Pharmaceutical Research and Development, Johnson & Johnson LLC , Spring House, PA 19477-0776, USA.
J Lipid Res. 2011 Feb;52(2):374-82. doi: 10.1194/jlr.D007971.
Endothelial lipase (EL) is a phospholipase A1 (PLA1) enzyme that hydrolyzes phospholipids at the sn-1 position to produce lysophospholipids and free fatty acids. Measurement of the PLA1 activity of EL is usually accomplished by the use of substrates that are also hydrolyzed by lipases in other subfamilies such as PLA2 enzymes. In order to distinguish PLA1 activity of EL from PLA2 enzymatic activity in cell-based assays, cell supernatants, and other nonhomogeneous systems, a novel fluorogenic substrate with selectivity toward PLA1 hydrolysis was conceived and characterized. This substrate was preferred by PLA1 enzymes, such as EL and hepatic lipase, and was cleaved with much lower efficiency by lipases that exhibit primarily triglyceride lipase activity, such as LPL or a lipase with PLA2 activity. The phospholipase activity detected by the PLA1 substrate could be inhibited with the small molecule esterase inhibitor ebelactone B. Furthermore, the PLA1 substrate was able to detect EL activity in human umbilical vein endothelial cells in a cell-based assay. This substrate is a useful reagent for identifying modulators of PLA1 enzymes, such as EL, and aiding in characterizing their mechanisms of action.
内皮脂肪酶(EL)是一种磷脂酶 A1(PLA1)酶,它可以在 sn-1 位置水解磷脂,生成溶血磷脂和游离脂肪酸。EL 的 PLA1 活性通常通过使用也被其他亚家族的脂肪酶(如 PLA2 酶)水解的底物来测量。为了区分基于细胞的测定法、细胞上清液和其他非均相系统中的 EL 的 PLA1 活性与 PLA2 酶活性,设计并表征了一种对 PLA1 水解具有选择性的新型荧光底物。这种底物被 PLA1 酶(如 EL 和肝脂肪酶)优先选择,而主要具有甘油三酯脂肪酶活性的脂肪酶(如 LPL 或具有 PLA2 活性的脂肪酶)对其的切割效率要低得多。PLA1 底物检测到的磷脂酶活性可以被小分子酯酶抑制剂埃贝拉酮 B 抑制。此外,PLA1 底物能够在基于细胞的测定法中检测到人脐静脉内皮细胞中的 EL 活性。这种底物是一种用于鉴定 PLA1 酶(如 EL)调节剂的有用试剂,并有助于表征它们的作用机制。